Outcomes of octogenarians undergoing holmium laser enucleation of prostate.
BPH
HoLEP
Octogenarian
Surgery
Journal
World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
received:
23
01
2022
accepted:
06
05
2022
pubmed:
29
5
2022
medline:
30
6
2022
entrez:
28
5
2022
Statut:
ppublish
Résumé
Holmium laser enucleation of prostate (HoLEP) is an effective surgical procedure in men with BPH. Due to the increase in the use of medical therapy for BPH related lower urinary symptoms more octogenarians are presenting in a delayed fashion with significant symptoms and urinary retention. We evaluate the feasibility and safety of octogenarians undergoing HoLEP. We performed a retrospective review of HoLEPs at our institution from July 2018 to December 2019. Patients were stratified into two groups based on age: < 80 and ≥ 80. A total of 458 patients were identified, with 74 (16.2%) ≥ 80. In patients ≥ 80, prostate volume was higher (p < 0.0005), there was a higher rate of antiplatelet/anticoagulation (p = 0.029) use, and a lower rate of alpha-blocker use (p = 0.0016). As expected, ASA scores which correlate with increasing number of concomitant diseases were greater in the ≥ 80 cohort (p = 0.016). There was no significant difference in intraoperative complications (p = 0.14), 90 day complication (p = 0.34), readmission rates (p = 0.425) or emergency room visits between groups (p = 0.15). Despite higher medical comorbidities and increased rates of anticoagulation in octogenarians, there is no increase in operative or postoperative complication rates. Age alone should not be used as exclusion criteria for HoLEP.
Identifiants
pubmed: 35633402
doi: 10.1007/s00345-022-04053-9
pii: 10.1007/s00345-022-04053-9
doi:
Substances chimiques
Anticoagulants
0
Holmium
W1XX32SQN1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1751-1754Informations de copyright
© 2022. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.
Références
Egan KB (2016) The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates. Urol Clin North Am 43(3):289–297. https://doi.org/10.1016/j.ucl.2016.04.001
doi: 10.1016/j.ucl.2016.04.001
pubmed: 27476122
Lim KB (2017) Epidemiology of clinical benign prostatic hyperplasia. Asian J Urol 4(3):148–151. https://doi.org/10.1016/j.ajur.2017.06.004
doi: 10.1016/j.ajur.2017.06.004
pubmed: 29264223
pmcid: 5717991
Elshal AM, Elmansy HM, Elhilali MM (2013) Transurethral laser surgery for benign prostate hyperplasia in octogenarians: safety and outcomes. Urology 81(3):634–639. https://doi.org/10.1016/j.urology.2012.11.042
doi: 10.1016/j.urology.2012.11.042
pubmed: 23332997
Nadu A et al (2004) Are indications for prostatectomy in octogenarians the same as for younger men? Int Urol Nephrol 36(1):47–50. https://doi.org/10.1023/b:urol.0000032683.36827.63
doi: 10.1023/b:urol.0000032683.36827.63
pubmed: 15338673
Cornu JN et al (2015) A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 67(6):1066–1096. https://doi.org/10.1016/j.eururo.2014.06.017
doi: 10.1016/j.eururo.2014.06.017
pubmed: 24972732
Large T et al (2020) Comparative study of holmium laser Enucleation of the prostate with MOSES enabled pulsed laser modulation. Urology 136:196–201. https://doi.org/10.1016/j.urology.2019.11.029
doi: 10.1016/j.urology.2019.11.029
pubmed: 31790785
Large T, Krambeck AE (2018) Evidence-based outcomes of holmium laser enucleation of the prostate. Curr Opin Urol 28(3):301–308. https://doi.org/10.1097/MOU.0000000000000498
doi: 10.1097/MOU.0000000000000498
pubmed: 29538164
Fitzpatrick JM (2006) The natural history of benign prostatic hyperplasia. BJU Int 97(S2):3–6. https://doi.org/10.1111/j.1464-410X.2006.06097.x
doi: 10.1111/j.1464-410X.2006.06097.x
pubmed: 16507045
Piao S et al (2016) Holmium laser enucleation of the prostate is safe for patients above 80 years: a prospective study. Int Neurourol J 20(2):143–150. https://doi.org/10.5213/inj.1630478.239
doi: 10.5213/inj.1630478.239
pubmed: 27377947
pmcid: 4932640
Tamalunas A et al (2020) The clinical value of holmium laser enucleation of the prostate in octogenarians. LUTS 13(2):279–285. https://doi.org/10.1111/luts.12366
doi: 10.1111/luts.12366
pubmed: 33260275
Descazeaud A et al (2009) Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a review. BJU Int 103(9):1162–1165. https://doi.org/10.1111/j.1464-410X.2008.08284.x
doi: 10.1111/j.1464-410X.2008.08284.x
pubmed: 19154457
Foster HE et al (2018) Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline. J Urol 200(3):612–619. https://doi.org/10.1016/j.juro.2018.05.048
doi: 10.1016/j.juro.2018.05.048
pubmed: 29775639
El Tayeb MM et al (2016) Holmium laser enucleation of the prostate in patients requiring anticoagulation. J Endourol 30(7):805–809. https://doi.org/10.1089/end.2016.0070
doi: 10.1089/end.2016.0070
pubmed: 27065437
Rivera M, Krambeck A, Lingeman J (2017) Holmium laser enucleation of the prostate in patients requiring anticoagulation. Curr Urol Rep 18(10):77. https://doi.org/10.1007/s11934-017-0727-2
doi: 10.1007/s11934-017-0727-2
pubmed: 28780634
Mmeje CO et al (2013) Age-stratified outcomes of holmium laser enucleation of the prostate. BJU Int 112(7):982–989. https://doi.org/10.1111/bju.12063
doi: 10.1111/bju.12063
pubmed: 23510326